These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30905814)

  • 1. Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer.
    Wei T; Zhang X; Zhang Q; Yang J; Chen Q; Wang J; Li X; Chen J; Ma T; Li G; Gao S; Lou J; Que R; Wang Y; Dang X; Zheng L; Liang T; Bai X
    Cancer Lett; 2019 Jun; 452():237-243. PubMed ID: 30905814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
    Poruk KE; Valero V; Saunders T; Blackford AL; Griffin JF; Poling J; Hruban RH; Anders RA; Herman J; Zheng L; Rasheed ZA; Laheru DA; Ahuja N; Weiss MJ; Cameron JL; Goggins M; Iacobuzio-Donahue CA; Wood LD; Wolfgang CL
    Ann Surg; 2016 Dec; 264(6):1073-1081. PubMed ID: 26756760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
    Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
    Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
    Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer.
    Cheng H; He W; Yang J; Ye Q; Cheng L; Pan Y; Mao L; Chu X; Lu C; Li G; Qiu Y; He J
    Cell Prolif; 2020 Sep; 53(9):e12880. PubMed ID: 32707596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
    Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
    Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EVALUATING MMP-2 AND TGFß-RI EXPRESSION IN CIRCULATING TUMOR CELLS OF PANCREATIC CANCER PATIENTS AND THEIR CORRELATION WITH CLINICAL EVOLUTION.
    Gasparini-Junior JL; Fanelli MF; Abdallah EA; Chinen LTD
    Arq Bras Cir Dig; 2019; 32(2):e1433. PubMed ID: 31038558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Tumor Cells Expressing Markers of Tumor-Initiating Cells Predict Poor Survival and Cancer Recurrence in Patients with Pancreatic Ductal Adenocarcinoma.
    Poruk KE; Blackford AL; Weiss MJ; Cameron JL; He J; Goggins M; Rasheed ZA; Wolfgang CL; Wood LD
    Clin Cancer Res; 2017 Jun; 23(11):2681-2690. PubMed ID: 27789528
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.
    Ankeny JS; Court CM; Hou S; Li Q; Song M; Wu D; Chen JF; Lee T; Lin M; Sho S; Rochefort MM; Girgis MD; Yao J; Wainberg ZA; Muthusamy VR; Watson RR; Donahue TR; Hines OJ; Reber HA; Graeber TG; Tseng HR; Tomlinson JS
    Br J Cancer; 2016 Jun; 114(12):1367-75. PubMed ID: 27300108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
    Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
    PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma.
    Torphy RJ; Tignanelli CJ; Kamande JW; Moffitt RA; Herrera Loeza SG; Soper SA; Yeh JJ
    PLoS One; 2014; 9(2):e89474. PubMed ID: 24586805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression.
    Satelli A; Batth I; Brownlee Z; Mitra A; Zhou S; Noh H; Rojas CR; Li H; Meng QH; Li S
    Oncotarget; 2017 Jul; 8(30):49329-49337. PubMed ID: 28521303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
    Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
    PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of epithelial-mesenchymal transitioned circulating tumor cells in patients with resectable gastric cancer: Relevance to therapy response.
    Li TT; Liu H; Li FP; Hu YF; Mou TY; Lin T; Yu J; Zheng L; Li GX
    World J Gastroenterol; 2015 Dec; 21(47):13259-67. PubMed ID: 26715808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer.
    Yu J; Yang M; Peng T; Liu Y; Cao Y
    Sci Rep; 2023 Nov; 13(1):18791. PubMed ID: 37914786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study.
    Yang L; Lv Z; Xia W; Zhang W; Xin Y; Yuan H; Chen Y; Hu X; Lv Y; Xu Q; Weng X; Ni C
    Clin Transl Oncol; 2018 Jul; 20(7):912-921. PubMed ID: 29243075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
    Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
    EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric Cancer.
    Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
    J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.